# Effects of Crestor on Inflammation of Atherosclerotic Plaques

> **NCT00689416** · EARLY_PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 74 (estimated)

## Conditions studied

- Atherosclerosis
- Inflammatory Activity in Carotid Arteries

## Interventions

- **DRUG:** rosuvastatin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00689416
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** —
- **Final completion:** 2009-06
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2009-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00689416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00689416, "Effects of Crestor on Inflammation of Atherosclerotic Plaques". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00689416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*